Dr. Reddy's Laboratories Limited
RDY
$13.47
$0.060.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.56% | -0.29% | -0.68% | 1.48% | 3.48% |
| Total Depreciation and Amortization | 21.23% | 16.59% | 12.46% | 11.74% | 9.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.71% | 193.32% | 157.09% | 71.72% | -44.36% |
| Change in Net Operating Assets | 45.45% | 1.84% | -46.92% | -205.08% | -719.57% |
| Cash from Operations | 66.83% | 19.51% | -0.70% | -33.83% | -53.36% |
| Capital Expenditure | -20.45% | -59.90% | -64.04% | -80.08% | -67.09% |
| Sale of Property, Plant, and Equipment | -76.10% | -72.71% | -52.32% | -45.06% | 87.93% |
| Cash Acquisitions | 96.89% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -462.09% | 170.69% | 187.60% | 160.71% | 111.81% |
| Cash from Investing | 31.14% | -6.65% | -41.72% | -24.12% | -19.92% |
| Total Debt Issued | -101.18% | -12.86% | 163.53% | 233.68% | 769.71% |
| Total Debt Repaid | -269.74% | -189.47% | 73.84% | 85.17% | 96.39% |
| Issuance of Common Stock | 64.47% | -50.34% | -76.02% | -78.59% | -81.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.10% | 1.09% | 1.09% | 1.09% | 1.09% |
| Other Financing Activities | -197.76% | 229.76% | 257.68% | 289.00% | 304.72% |
| Cash from Financing | -142.06% | 16.54% | 597.54% | 434.86% | 345.66% |
| Foreign Exchange rate Adjustments | 543.88% | 698.99% | 454.01% | 10.33% | 117.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.79% | 281.55% | 430.31% | 308.11% | -151.26% |